Biofeedback therapy for intractable tinnitus.

Benzodiazepine receptor distribution in severe intractable tinnitus.

Tinnitus affects nearly 50 million people in the United States, with a minority demonstrating marked functional impairment. Alterations of gamma aminobutyric acid (GABA) neuronal function and benzodiazepine receptor (BZR) function in particular have been implicated in the pathophysiology of severe, chronic tinnitus. The purpose of our study was to evaluate the distribution of BZR in the brain u...

Multimodal therapy for chronic tinnitus.

From 2001 to 2006, we performed a retrospective study of patients suffering from chronic unilateral or bilateral tinnitus that was previously ineffectively treated by oral drugs [betahistine (Betaserc), extract of Ginkgo biloba (EGb 761), tanakan (Tebokan), and cinnarizine-dimenhydrinate (Arlevert), singly or in combination]. We divided 150 tinnitus patients (80 men, 70 women) into seven treatm...

Idiopathic Subjective Tinnitus Treated by Amitriptyline Hydrochloride/Biofeedback.

The efficiency of two treatment modalities for subjective/idiopathic tinnitus (SIT): biofeedback (BF) and amitriptyline hydrochloride (AT) was investigated in 225 randomly selected subjects. Findings show that after 10 weeks of treatment in the BF group, 43.5% of the patients reported an improvement of tinnitus during activity. In the AT group, 27.5% of patients reported subjective improvement ...

Schuhfried Biofeedback System Bibliography for Migraine Therapy

Lafayette Instrument Company February 15, 2007 Cohen, M. J., D. L. McArthur, et al. (1980). "Comparison of four biofeedback treatments for migraine headache: Psychological and headache variables." Psychosomatic Medicine 42(5): 463-480. 42 migraine headache patients (mean age 42 yrs) participated in an appraisal of biofeedback for differential finger warming--forehead cooling, frontalis EMG rela...

Tinnitus Retraining Therapy